Q3  2024 |
≡ |
Thomas Gayner - Markel Group |
Add 23.94% |
17,000 |
0.01 |
≡ |
Samantha McLemore - Patient Capital Management |
Sell 100.00% |
26,183 |
0.10 |
≡ |
David Tepper - Appaloosa Management |
Reduce 6.00% |
90,000 |
0.10 |
≡ |
Thomas Russo - Gardner Russo & Quinn |
Add 4.19% |
152,667 |
0.12 |
≡ |
Chase Coleman - Tiger Global Management |
Reduce 13.60% |
408,818 |
0.13 |
≡ |
William Von Mueffling - Cantillon Capital Management |
Add 65.17% |
1,587,208 |
0.73 |
≡ |
John Armitage - Egerton Capital |
Add 89.40% |
1,595,839 |
1.21 |
≡ |
Daniel Loeb - Third Point |
Sell 100.00% |
2,100,000 |
1.76 |
≡ |
Lee Ainslie - Maverick Capital |
Sell 100.00% |
1,404,425 |
1.94 |
Q2  2024 |
≡ |
Thomas Gayner - Markel Group |
Add 22.41% |
13,000 |
0.01 |
≡ |
David Tepper - Appaloosa Management |
Add 10.29% |
140,000 |
0.17 |
≡ |
Thomas Russo - Gardner Russo & Quinn |
Add 10.44% |
344,484 |
0.26 |
≡ |
Lee Ainslie - Maverick Capital |
Add 28.01% |
307,291 |
0.42 |
≡ |
Chuck Akre - Akre Capital Management |
Sell 100.00% |
1,775,000 |
1.13 |
≡ |
William Von Mueffling - Cantillon Capital Management |
Buy |
2,435,442 |
1.18 |
≡ |
John Armitage - Egerton Capital |
Buy |
1,785,119 |
1.31 |
≡ |
Daniel Loeb - Third Point |
Add 320.00% |
1,600,000 |
1.34 |
≡ |
Samantha McLemore - Patient Capital Management |
Reduce 94.47% |
447,284 |
1.71 |
Q1  2024 |
≡ |
Thomas Gayner - Markel Group |
Add 28.89% |
13,000 |
0.01 |
≡ |
Chase Coleman - Tiger Global Management |
Reduce 1.31% |
40,004 |
0.02 |
≡ |
Steven Romick - FPA Crescent Fund |
Reduce 12.45% |
135,315 |
0.17 |
≡ |
Thomas Russo - Gardner Russo & Quinn |
Add 7.10% |
218,865 |
0.17 |
≡ |
Samantha McLemore - Patient Capital Management |
Reduce 18.61% |
108,266 |
0.40 |
≡ |
Daniel Loeb - Third Point |
Reduce 50.00% |
500,000 |
0.49 |
≡ |
Lee Ainslie - Maverick Capital |
Reduce 31.59% |
506,709 |
0.76 |
≡ |
Chuck Akre - Akre Capital Management |
Buy |
1,775,000 |
1.13 |
≡ |
David Tepper - Appaloosa Management |
Reduce 77.33% |
4,640,000 |
5.32 |
Q4  2023 |
≡ |
Thomas Gayner - Markel Group |
Add 114.29% |
24,000 |
0.02 |
≡ |
Steven Romick - FPA Crescent Fund |
Reduce 23.56% |
335,083 |
0.35 |
≡ |
Chase Coleman - Tiger Global Management |
Reduce 40.64% |
2,086,300 |
0.91 |
≡ |
Samantha McLemore - Patient Capital Management |
Reduce 36.31% |
331,684 |
1.08 |
≡ |
Lee Ainslie - Maverick Capital |
Reduce 37.98% |
982,125 |
1.25 |
≡ |
David Tepper - Appaloosa Management |
Reduce 17.24% |
1,250,000 |
1.36 |
≡ |
Thomas Russo - Gardner Russo & Quinn |
Buy |
3,081,363 |
1.93 |
≡ |
Daniel Loeb - Third Point |
Reduce 76.19% |
3,200,000 |
2.98 |
Q3  2023 |
≡ |
Thomas Gayner - Markel Group |
Add 200.00% |
14,000 |
0.01 |
≡ |
David Tepper - Appaloosa Management |
Add 1.40% |
100,000 |
0.09 |
≡ |
Steven Romick - FPA Crescent Fund |
Reduce 11.86% |
191,403 |
0.15 |
≡ |
Lee Ainslie - Maverick Capital |
Reduce 9.02% |
256,489 |
0.28 |
≡ |
Chase Coleman - Tiger Global Management |
Add 44.31% |
1,576,000 |
0.53 |
≡ |
Daniel Loeb - Third Point |
Add 51.35% |
1,425,000 |
1.01 |
≡ |
Samantha McLemore - Patient Capital Management |
Reduce 34.40% |
478,988 |
1.30 |
Q2  2023 |
≡ |
Thomas Gayner - Markel Group |
Buy |
7,000 |
0.00 |
≡ |
Lee Ainslie - Maverick Capital |
Reduce 0.95% |
27,298 |
0.03 |
≡ |
Steven Romick - FPA Crescent Fund |
Reduce 7.64% |
133,514 |
0.09 |
≡ |
David Tepper - Appaloosa Management |
Add 19.17% |
1,150,000 |
0.92 |
≡ |
Chase Coleman - Tiger Global Management |
Add 492.83% |
2,957,000 |
1.06 |
≡ |
Daniel Loeb - Third Point |
Buy |
2,775,000 |
1.76 |
≡ |
Bill Miller - Miller Value Partners |
Sell 100.00% |
1,382,513 |
2.74 |
≡ |
Samantha McLemore - Patient Capital Management |
Add 623.70% |
1,200,005 |
2.89 |
Q1  2023 |
≡ |
Samantha McLemore - Patient Capital Management |
Reduce 12.62% |
27,800 |
0.40 |
≡ |
Bill Miller - Miller Value Partners |
Reduce 17.11% |
285,432 |
0.57 |
≡ |
Viking Global Investors |
Sell 100.00% |
7,939,999 |
0.99 |
≡ |
Lee Ainslie - Maverick Capital |
Reduce 36.20% |
1,628,123 |
1.33 |
≡ |
David Tepper - Appaloosa Management |
Add 389.80% |
4,775,000 |
8.18 |
Q4  2022 |
≡ |
Lee Ainslie - Maverick Capital |
Add 1.03% |
45,906 |
0.03 |
≡ |
Samantha McLemore - Patient Capital Management |
Reduce 4.22% |
9,700 |
0.12 |
≡ |
Bill Miller - Miller Value Partners |
Reduce 8.61% |
157,130 |
0.25 |
≡ |
David Tepper - Appaloosa Management |
Add 22.50% |
225,000 |
0.41 |
≡ |
Viking Global Investors |
Reduce 51.57% |
8,456,108 |
1.05 |
≡ |
Chase Coleman - Tiger Global Management |
Reduce 93.95% |
9,323,073 |
2.80 |
Q3  2022 |
≡ |
Viking Global Investors |
Reduce 1.13% |
187,516 |
0.02 |
≡ |
Samantha McLemore - Patient Capital Management |
Add 1.66% |
3,750 |
0.05 |
≡ |
Lee Ainslie - Maverick Capital |
Reduce 8.79% |
428,976 |
0.26 |
≡ |
Bill Miller - Miller Value Partners |
Add 15.66% |
247,084 |
0.40 |
≡ |
Chase Coleman - Tiger Global Management |
Add 1501.66% |
9,303,523 |
2.26 |
Q2  2022 |
≡ |
Steven Romick - FPA Crescent Fund |
Add 13.52% |
208,117 |
0.08 |
≡ |
Chase Coleman - Tiger Global Management |
Reduce 50.22% |
624,952 |
0.11 |
≡ |
Bill Miller - Miller Value Partners |
Add 17.07% |
230,095 |
0.26 |
≡ |
Viking Global Investors |
Add 58.89% |
6,146,424 |
0.58 |
≡ |
Lee Ainslie - Maverick Capital |
Add 31.46% |
1,167,992 |
0.60 |
≡ |
Samantha McLemore - Patient Capital Management |
Add 46.09% |
71,350 |
0.72 |
≡ |
David Tepper - Appaloosa Management |
Reduce 50.50% |
1,020,000 |
1.31 |
Q1  2022 |
≡ |
Viking Global Investors |
Reduce 1.39% |
147,595 |
0.02 |
≡ |
Samantha McLemore - Patient Capital Management |
Add 3.34% |
5,000 |
0.07 |
≡ |
Bill Miller - Miller Value Partners |
Add 9.67% |
118,839 |
0.16 |
≡ |
Steven Romick - FPA Crescent Fund |
Add 30.03% |
355,480 |
0.19 |
≡ |
Lee Ainslie - Maverick Capital |
Add 15.05% |
485,566 |
0.31 |
≡ |
Chase Coleman - Tiger Global Management |
Reduce 93.10% |
16,785,573 |
2.29 |
≡ |
David Tepper - Appaloosa Management |
Add 797.78% |
1,795,000 |
2.56 |
Q4  2021 |
≡ |
Bill Miller - Miller Value Partners |
Add 12.34% |
135,012 |
0.20 |
≡ |
Chase Coleman - Tiger Global Management |
Reduce 13.08% |
2,713,423 |
0.25 |
≡ |
Lee Ainslie - Maverick Capital |
Add 32.74% |
795,962 |
0.40 |
≡ |
Viking Global Investors |
Add 65.60% |
4,192,950 |
0.51 |
≡ |
Steven Romick - FPA Crescent Fund |
Buy |
1,183,677 |
0.68 |
≡ |
David Tepper - Appaloosa Management |
Reduce 88.46% |
1,725,500 |
1.84 |
Q3  2021 |
≡ |
Chase Coleman - Tiger Global Management |
Reduce 0.02% |
4,357 |
0.00 |
≡ |
David Tepper - Appaloosa Management |
Reduce 4.15% |
84,500 |
0.09 |
≡ |
Lee Ainslie - Maverick Capital |
Add 10.23% |
225,570 |
0.11 |
≡ |
Bill Miller - Miller Value Partners |
Reduce 9.54% |
115,377 |
0.18 |
≡ |
Viking Global Investors |
Buy |
6,391,844 |
0.80 |
≡ |
Daniel Loeb - Third Point |
Sell 100.00% |
8,350,000 |
2.45 |
Q2  2021 |
≡ |
Chase Coleman - Tiger Global Management |
Reduce 0.35% |
73,857 |
0.01 |
≡ |
Bill Miller - Miller Value Partners |
Add 1.61% |
19,206 |
0.03 |
≡ |
Lee Ainslie - Maverick Capital |
Add 36.05% |
584,494 |
0.28 |
≡ |
Daniel Loeb - Third Point |
Add 23.70% |
1,600,000 |
0.47 |
≡ |
David Tepper - Appaloosa Management |
Buy |
2,035,000 |
2.11 |
Q1  2021 |
≡ |
Bill Miller - Miller Value Partners |
Reduce 3.40% |
41,855 |
0.06 |
≡ |
Lee Ainslie - Maverick Capital |
Add 206.74% |
1,092,785 |
0.56 |
≡ |
Chase Coleman - Tiger Global Management |
Reduce 24.78% |
6,859,687 |
0.86 |